Filing Details

Accession Number:
0001415889-24-019169
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-03 16:13:01
Reporting Period:
2024-07-02
Accepted Time:
2024-07-03 16:13:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623526 Stoke Therapeutics Inc. STOK Pharmaceutical Preparations (2834) 471144582
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780085 M. Huw Nash C/O Stoke Therapeutics, Inc.
45 Wiggins Avenue
Bedford MA 01730
Chief Business Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-02 2,467 $13.10 33 No 4 S Direct
Common Stock Disposition 2024-07-02 33 $13.90 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2023.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.83 to $13.74 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The shares sold in the reported transactions include an aggregate 2,500 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).